 |
 |
 |
|
Antiviral Activity and Resistance Profile of the Novel HCV NS5A Inhibitor GS-5885
|
|
|
Reported by Jules Levin EASL 2012 Apr 18-22 Barcelona Spain
G Cheng, B Peng, A Corsa, M Yu, M Nash, YJ Lee, Y Xu, T Kirschberg, Y Tian, J Taylor, J Link, W Delaney IV
Gilead Sciences, Inc. , 333 Lakeside Drive, Foster City, CA 94404, USA







|
|
|
 |
 |
|
|